Published in Neurology on February 16, 2011
Effects of tDCS on Verbal Short-term Memory in Neurodegenerative Disorders | NCT03887481
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain (2011) 9.90
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 6.84
Criteria for the diagnosis of corticobasal degeneration. Neurology (2013) 3.07
Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain (2012) 2.65
Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain (2012) 2.43
Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain (2012) 2.29
Neurobiological roots of language in primate audition: common computational properties. Trends Cogn Sci (2015) 2.25
Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol (2011) 2.17
Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain (2011) 2.13
Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion. Acta Neuropathol (2012) 2.01
The muted sense: neurocognitive limitations of olfactory language. Trends Cogn Sci (2015) 2.00
Functional network disruption in the degenerative dementias. Lancet Neurol (2011) 1.98
The neuropsychological profile of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.93
Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. Brain (2013) 1.91
Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol (2013) 1.89
Frontotemporal dementia and its subtypes: a genome-wide association study. Lancet Neurol (2014) 1.88
How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders? Curr Opin Neurol (2012) 1.81
TDP-43 frontotemporal lobar degeneration and autoimmune disease. J Neurol Neurosurg Psychiatry (2013) 1.74
White matter damage in primary progressive aphasias: a diffusion tensor tractography study. Brain (2011) 1.73
CSF biomarkers cutoffs: the importance of coincident neuropathological diseases. Acta Neuropathol (2012) 1.70
The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum. Ann Med (2012) 1.66
Quantitative application of the primary progressive aphasia consensus criteria. Neurology (2014) 1.64
Quantitative classification of primary progressive aphasia at early and mild impairment stages. Brain (2012) 1.62
Logopenic and nonfluent variants of primary progressive aphasia are differentiated by acoustic measures of speech production. PLoS One (2014) 1.57
Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study. Alzheimers Dement (2014) 1.56
Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia. Brain (2014) 1.54
Can MRI screen for CSF biomarkers in neurodegenerative disease? Neurology (2012) 1.52
C9orf72 promoter hypermethylation is neuroprotective: Neuroimaging and neuropathologic evidence. Neurology (2015) 1.52
C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts. Neurology (2012) 1.44
Regional β-amyloid burden does not correlate with cognitive or language deficits in Alzheimer's disease presenting as aphasia. Eur J Neurol (2015) 1.43
Eating behavior in frontotemporal dementia: Peripheral hormones vs hypothalamic pathology. Neurology (2015) 1.43
Comparison of cerebrospinal fluid levels of tau and Aβ 1-42 in Alzheimer disease and frontotemporal degeneration using 2 analytical platforms. Arch Neurol (2012) 1.42
The genetics and neuropathology of frontotemporal lobar degeneration. Acta Neuropathol (2012) 1.42
Progression of language decline and cortical atrophy in subtypes of primary progressive aphasia. Neurology (2011) 1.42
Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain. Mol Neurodegener (2016) 1.41
The non-fluent/agrammatic variant of primary progressive aphasia. Lancet Neurol (2012) 1.33
Influence of comorbidities in idiopathic normal pressure hydrocephalus - research and clinical care. A report of the ISHCSF task force on comorbidities in INPH. Fluids Barriers CNS (2013) 1.33
A novel frontal pathway underlies verbal fluency in primary progressive aphasia. Brain (2013) 1.32
Syntactic processing depends on dorsal language tracts. Neuron (2011) 1.31
Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia. Brain (2012) 1.26
Words and objects at the tip of the left temporal lobe in primary progressive aphasia. Brain (2013) 1.26
Estimating the number of persons with frontotemporal lobar degeneration in the US population. J Mol Neurosci (2011) 1.25
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Brain (2016) 1.25
Frontotemporal dementia: implications for understanding Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.23
Assessing clinicopathological correlation in chronic traumatic encephalopathy: rationale and methods for the UNITE study. Alzheimers Res Ther (2015) 1.22
Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (2012) 1.21
Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine. Acta Neuropathol (2014) 1.21
Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease. Neurology (2015) 1.20
Neural correlates of syntactic processing in the nonfluent variant of primary progressive aphasia. J Neurosci (2010) 1.20
Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer's disease. FASEB J (2014) 1.20
Syndromes dominated by apraxia of speech show distinct characteristics from agrammatic PPA. Neurology (2013) 1.19
The paradox of syndromic diversity in Alzheimer disease. Nat Rev Neurol (2012) 1.18
Dissociations Between Fluency And Agrammatism In Primary Progressive Aphasia. Aphasiology (2012) 1.17
Primary progressive aphasia: a tale of two syndromes and the rest. Neurology (2012) 1.17
Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration. Ann Neurol (2014) 1.15
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier). Alzheimers Dement (2012) 1.14
Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation. Brain (2015) 1.14
Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD). Acta Neuropathol (2014) 1.14
Clinical review. Frontotemporal dementia. BMJ (2013) 1.13
Handedness and language learning disability differentially distribute in progressive aphasia variants. Brain (2013) 1.13
Distinguishing Alzheimer's disease from other major forms of dementia. Expert Rev Neurother (2011) 1.12
The function of the left anterior temporal pole: evidence from acute stroke and infarct volume. Brain (2011) 1.10
Early-onset Alzheimer disease clinical variants: multivariate analyses of cortical thickness. Neurology (2012) 1.10
The epidemiology of frontotemporal dementia. Int Rev Psychiatry (2013) 1.09
Distinct regional anatomic and functional correlates of neurodegenerative apraxia of speech and aphasia: an MRI and FDG-PET study. Brain Lang (2013) 1.09
TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathol (2014) 1.08
The brain basis of musicophilia: evidence from frontotemporal lobar degeneration. Front Psychol (2013) 1.07
Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applications. Alzheimers Res Ther (2011) 1.07
The logopenic variant of primary progressive aphasia. Curr Opin Neurol (2010) 1.06
Positive effects of language treatment for the logopenic variant of primary progressive aphasia. J Mol Neurosci (2011) 1.05
White matter imaging contributes to the multimodal diagnosis of frontotemporal lobar degeneration. Neurology (2012) 1.05
Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier. Acta Neuropathol (2014) 1.04
Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia. BMC Neurol (2013) 1.04
THE QUICK DEMENTIA RATING SYSTEM (QDRS): A RAPID DEMENTIA STAGING TOOL. Alzheimers Dement (Amst) (2015) 1.02
Low neural exosomal levels of cellular survival factors in Alzheimer's disease. Ann Clin Transl Neurol (2015) 1.02
Anterior temporal lobe degeneration produces widespread network-driven dysfunction. Brain (2013) 1.02
Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease. Neuroimage Clin (2013) 1.02
Patterns of longitudinal brain atrophy in the logopenic variant of primary progressive aphasia. Brain Lang (2013) 1.02
Primary progressive aphasia and the evolving neurology of the language network. Nat Rev Neurol (2014) 1.02
The role of domain-general cognitive control in language comprehension. Front Psychol (2014) 1.02
MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease. PLoS One (2015) 1.02
Disruption of large-scale neural networks in non-fluent/agrammatic variant primary progressive aphasia associated with frontotemporal degeneration pathology. Brain Lang (2012) 1.01
The power of neuroimaging biomarkers for screening frontotemporal dementia. Hum Brain Mapp (2014) 1.00
Gray matter density of auditory association cortex relates to knowledge of sound concepts in primary progressive aphasia. J Neurosci (2012) 1.00
Verb and noun deficits in stroke-induced and primary progressive aphasia: The Northwestern Naming Battery(). Aphasiology (2012) 1.00
The evolution of primary progressive apraxia of speech. Brain (2014) 0.99
Nonamnestic presentations of early-onset Alzheimer's disease. Am J Alzheimers Dis Other Demen (2012) 0.99
Converging evidence for the neuroanatomic basis of combinatorial semantics in the angular gyrus. J Neurosci (2015) 0.99
Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome. Alzheimers Res Ther (2013) 0.99
Syntactic and morphosyntactic processing in stroke-induced and primary progressive aphasia. Behav Neurol (2013) 0.97
Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development. Alzheimers Dement (2012) 0.96
FDG PET and MRI in logopenic primary progressive aphasia versus dementia of the Alzheimer's type. PLoS One (2013) 0.96
Cognitive and behavioral features of c9FTD/ALS. Alzheimers Res Ther (2012) 0.96
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease. Mol Neurodegener (2016) 0.96
Asymmetry of cortical decline in subtypes of primary progressive aphasia. Neurology (2014) 0.95
The effect of the serotonin transporter polymorphism (5-HTTLPR) on empathic and self-conscious emotional reactivity. Emotion (2012) 0.95
Self-projection and the default network in frontotemporal dementia. Nat Rev Neurol (2012) 0.95
White matter tract signatures of the progressive aphasias. Neurobiol Aging (2013) 0.95
Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease. Front Aging Neurosci (2013) 0.94
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology (1998) 26.77
Neurodegenerative diseases target large-scale human brain networks. Neuron (2009) 9.69
Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol (2004) 7.07
Slowly progressive aphasia without generalized dementia. Ann Neurol (1982) 5.66
Semantic dementia. Progressive fluent aphasia with temporal lobe atrophy. Brain (1992) 5.63
Frontotemporal dementia: clinicopathological correlations. Ann Neurol (2006) 5.14
Clinicopathological correlates in frontotemporal dementia. Ann Neurol (2004) 4.38
Clinical and pathological characterization of progressive aphasia. Ann Neurol (2006) 4.37
A voxel-based morphometry study of semantic dementia: relationship between temporal lobe atrophy and semantic memory. Ann Neurol (2000) 4.22
Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol (2008) 4.15
Differing patterns of temporal atrophy in Alzheimer's disease and semantic dementia. Neurology (2001) 4.10
Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain (2006) 4.07
Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol (2008) 3.99
The logopenic/phonological variant of primary progressive aphasia. Neurology (2008) 3.95
Primary progressive aphasia. Ann Neurol (2001) 3.72
Non-verbal semantic impairment in semantic dementia. Neuropsychologia (2000) 3.64
The selective impairment of semantic memory. Q J Exp Psychol (1975) 3.63
The evolution and pathology of frontotemporal dementia. Brain (2005) 3.46
Primary progressive aphasia--a language-based dementia. N Engl J Med (2003) 3.14
The pathological basis of semantic dementia. Brain (2005) 2.96
Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. Arch Neurol (2007) 2.68
Quantitative template for subtyping primary progressive aphasia. Arch Neurol (2009) 2.42
Progressive non-fluent aphasia is associated with hypometabolism centred on the left anterior insula. Brain (2003) 2.25
The natural history of temporal variant frontotemporal dementia. Neurology (2005) 2.22
Connected speech production in three variants of primary progressive aphasia. Brain (2010) 2.19
Primary progressive aphasia: a review. Neurocase (2004) 2.08
Nonfluent progressive aphasia and semantic dementia: a comparative neuropsychological study. J Int Neuropsychol Soc (1996) 2.04
Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia. Brain (2006) 2.00
Progressive prosopagnosia associated with selective right temporal lobe atrophy. A new syndrome? Brain (1995) 1.89
Distinct patterns of olfactory impairment in Alzheimer's disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration. Neuropsychologia (2006) 1.80
Progressive nonfluent aphasia and its characteristic motor speech deficits. Alzheimer Dis Assoc Disord (2007) 1.78
Semantic dementia and fluent primary progressive aphasia: two sides of the same coin? Brain (2006) 1.76
Spectrum of primary progressive aphasia. Baillieres Clin Neurol (1992) 1.58
Hereditary frontotemporal dementia caused by Tau gene mutations. Brain Pathol (2007) 1.57
TDP-43 pathologic lesions and clinical phenotype in frontotemporal lobar degeneration with ubiquitin-positive inclusions. Arch Neurol (2007) 1.57
Reversal of the concreteness effect for verbs in patients with semantic dementia. Neuropsychology (2007) 1.48
Different patterns of famous people recognition disorders in patients with right and left anterior temporal lesions: a systematic review. Neuropsychologia (2007) 1.47
The core and halo of primary progressive aphasia and semantic dementia. Ann Neurol (2003) 1.39
The neural basis of surface dyslexia in semantic dementia. Brain (2008) 1.36
Neuropsychological decline in frontotemporal lobar degeneration: a longitudinal analysis. Neuropsychology (2009) 1.35
Patterns of cerebral atrophy in primary progressive aphasia. Am J Geriatr Psychiatry (2002) 1.34
The relation between content and structure in language production: an analysis of speech errors in semantic dementia. Brain Lang (2009) 1.26
Nuclear imaging can predict pathologic diagnosis in progressive nonfluent aphasia. Neurology (2007) 1.24
Mapping the progression of progranulin-associated frontotemporal lobar degeneration. Nat Clin Pract Neurol (2008) 1.17
Progressive anomia revisited: focal degeneration associated with progranulin gene mutation. Neurocase (2007) 1.06
Familial primary progressive aphasia. Alzheimer Dis Assoc Disord (2003) 1.02
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology (1998) 26.77
Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain. Med Image Anal (2007) 13.54
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33
A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology (2000) 10.75
Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol (2001) 9.96
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology (1999) 9.86
Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med (2000) 6.83
Understanding normal and impaired word reading: computational principles in quasi-regular domains. Psychol Rev (1996) 6.31
Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain (2008) 6.29
A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group. JAMA (1994) 5.98
A cortical network for directed attention and unilateral neglect. Ann Neurol (1981) 5.91
Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology (2004) 5.86
The prevalence of frontotemporal dementia. Neurology (2002) 5.73
Slowly progressive aphasia without generalized dementia. Ann Neurol (1982) 5.66
Semantic dementia. Progressive fluent aphasia with temporal lobe atrophy. Brain (1992) 5.63
Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol (2003) 5.17
Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology (2002) 5.03
Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology (2005) 5.02
Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology (2000) 4.89
Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology (2004) 4.74
Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology (2002) 4.50
Tetramethyl benzidine for horseradish peroxidase neurohistochemistry: a non-carcinogenic blue reaction product with superior sensitivity for visualizing neural afferents and efferents. J Histochem Cytochem (1978) 4.36
Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology (2008) 4.31
A potential noninvasive neurobiological test for Alzheimer's disease. Science (1994) 4.29
Insula of the old world monkey. III: Efferent cortical output and comments on function. J Comp Neurol (1982) 4.23
A voxel-based morphometry study of semantic dementia: relationship between temporal lobe atrophy and semantic memory. Ann Neurol (2000) 4.22
Dyslexia: cultural diversity and biological unity. Science (2001) 4.17
In vivo nitrate reduction in relation to nitrate uptake, nitrate content, and in vitro nitrate reductase activity in intact barley seedlings. Plant Physiol (1976) 4.16
Differing patterns of temporal atrophy in Alzheimer's disease and semantic dementia. Neurology (2001) 4.10
Focal cortical presentations of Alzheimer's disease. Brain (2007) 4.07
The neural basis of the central executive system of working memory. Nature (1995) 4.03
The assessment of binge eating severity among obese persons. Addict Behav (1982) 4.02
The logopenic/phonological variant of primary progressive aphasia. Neurology (2008) 3.95
Chlamydial infections. Annu Rev Med (1981) 3.94
Pupil-led sex education in England (RIPPLE study): cluster-randomised intervention trial. Lancet (2004) 3.86
Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology (2000) 3.84
Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging. Neurology (2010) 3.83
MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology (2009) 3.72
Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology (2007) 3.71
Cognitive impairment in hemodialysis patients is common. Neurology (2006) 3.68
Non-verbal semantic impairment in semantic dementia. Neuropsychologia (2000) 3.64
Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology (2006) 3.60
In vivo confocal scanning laser microscopy of human skin: melanin provides strong contrast. J Invest Dermatol (1995) 3.53
Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology (2004) 3.41
Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience (1983) 3.26
MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology (2007) 3.24
Cerebral MRI findings and cognitive functioning: the Atherosclerosis Risk in Communities study. Neurology (2005) 3.21
Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol (1983) 3.19
Race/ethnic differences in AD survival in US Alzheimer's Disease Centers. Neurology (2007) 3.18
Attention and executive deficits in Alzheimer's disease. A critical review. Brain (1999) 3.15
Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain (2000) 3.14
The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging. Neurology (2012) 3.01
The emerging role of the emergency care practitioner. Emerg Med J (2004) 2.95
Atrophy rates accelerate in amnestic mild cognitive impairment. Neurology (2007) 2.93
Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature. J Neurol Neurosurg Psychiatry (2000) 2.90
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology (2007) 2.86
MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations. Neurology (2009) 2.83
Semantic effects in single-word naming. J Exp Psychol Learn Mem Cogn (1995) 2.80
Prospective study of chlamydial infection in neonates. Lancet (1979) 2.80
Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain (2000) 2.76
Impaired recognition and experience of disgust following brain injury. Nat Neurosci (2000) 2.76
Qualitative mapping of cerebral blood flow and functional localization with echo-planar MR imaging and signal targeting with alternating radio frequency. Radiology (1994) 2.74
MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study. Neurology (2008) 2.69
A cultural effect on brain function. Nat Neurosci (2000) 2.69
Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease. Neurology (2012) 2.68
Functional localization of the system for visuospatial attention using positron emission tomography. Brain (1997) 2.67
11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology (2007) 2.65
Memory and MRI-based hippocampal volumes in aging and AD. Neurology (2000) 2.65
Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD. Neurology (2011) 2.61
Direct and indirect gene replacements in Aspergillus nidulans. Mol Cell Biol (1985) 2.61
Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry (2002) 2.60
Insula of the old world monkey. I. Architectonics in the insulo-orbito-temporal component of the paralimbic brain. J Comp Neurol (1982) 2.57
Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease? J Neurol Neurosurg Psychiatry (2000) 2.57
Insula of the old world monkey. II: Afferent cortical input and comments on the claustrum. J Comp Neurol (1982) 2.54
Report of IFCN Committee on Basic Mechanisms. Basic mechanisms of cerebral rhythmic activities. Electroencephalogr Clin Neurophysiol (1990) 2.50
REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology (2010) 2.50
Activities of daily living in frontotemporal dementia and Alzheimer disease. Neurology (2007) 2.49
Hunger selectively modulates corticolimbic activation to food stimuli in humans. Behav Neurosci (2001) 2.49
Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study. Hum Gene Ther (1993) 2.48
Reporting potential bias: Neurology's evolving policies. Neurology (2011) 2.46
Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum. Neurology (2009) 2.46